[HTML][HTML] Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis
Technological advances in passive digital phenotyping present the opportunity to quantify
neurological diseases using new approaches that may complement clinical assessments.
Here, we studied multiple sclerosis (MS) as a model neurological disease for investigating
physiometric and environmental signals. The objective of this study was to assess the
feasibility and correlation of wearable biosensors with traditional clinical measures of
disability both in clinic and in free-living in MS patients. This is a single site observational�…
neurological diseases using new approaches that may complement clinical assessments.
Here, we studied multiple sclerosis (MS) as a model neurological disease for investigating
physiometric and environmental signals. The objective of this study was to assess the
feasibility and correlation of wearable biosensors with traditional clinical measures of
disability both in clinic and in free-living in MS patients. This is a single site observational�…
[CITATION][C] Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis. npj Digit Med. 2019 Dec; 2: 123
T Chitnis, BI Glanz, C Gonzalez, BC Healy… - 2019
Showing the best results for this search. See all results